Literature DB >> 2374236

High grade vesicoureteral reflux: analysis of observational therapy.

G A McLorie1, P H McKenna, B M Jumper, B M Churchill, R F Gilmour, A E Khoury.   

Abstract

Between 1981 and 1987, 300 patients with high grade (III, IV and V international classification) vesicoureteral reflux were treated at a single pediatric hospital. Only patients with primary vesicoureteral reflux were included in the study. The guiding principle during this period was that all patients with high grade vesicoureteral reflux would be observed on prophylactic antibiotics (observational therapy) and surgical correction would be reserved for specific indications. Of the 300 patients 132 received observational therapy alone and 168 required surgical correction for specific indications after varying periods of observation. In both groups the duration of persistent reflux was analyzed using a life-table method. In patients with grade V reflux we observed resolution in 3 patients whereas 23 required surgical correction. Of those patients in the observation group with grade IV reflux 83% had persistent reflux at 2 years and 70% still had reflux at 5 years. For those with grade III reflux the persistence rate was 83% and 50%, respectively. Neither age, sex nor side of reflux had a correlation with the rate of resolution. When tested grade of reflux correlated loosely (p = 0.07). During the period of observational therapy new renal scars developed in 23 patients (8%). We conclude that high grade vesicoureteral reflux can resolve in a minority of patients over a protracted interval. On the basis of this analysis, we advocate consideration of surgical correction in these patients after a 4-year period of observational therapy and for specific indications.

Entities:  

Mesh:

Year:  1990        PMID: 2374236     DOI: 10.1016/s0022-5347(17)39516-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Postoperative medium-term follow-up of patients with bilateral, massive primary vesicorenal reflux and reduced renal function at presentation.

Authors:  G Belloli; G Bolla; F Cappellari; L Musi
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

2.  Effect of prednisolone on ascending renal infection due to biofilm disease and lower urinary tract obstruction in rats.

Authors:  M Haraoka; T Matsumoto; K Takahashi; S Kubo; M Tanaka; J Kumazawa
Journal:  Urol Res       Date:  1995

3.  Vitamin E administration at the onset of fever prevents renal scarring in acute pyelonephritis.

Authors:  Zhina Sadeghi; Abdol-Mohammad Kajbafzadeh; Parvin Tajik; Maryam Monajemzadeh; Seyedmehdi Payabvash; Azadeh Elmi
Journal:  Pediatr Nephrol       Date:  2008-06-04       Impact factor: 3.714

4.  The effects of methylene blue on renal scarring due to pyelonephritis in rats.

Authors:  Burhan Aksu; Mustafa Inan; Mehmet Kanter; Fulya Oz Puyan; Hafize Uzun; Gulay Durmus-Altun; Saban Gurcan; Seval Aydin; Suleyman Ayvaz; Mehmet Pul
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

5.  The demographic burden of urologic diseases in America.

Authors:  David C Miller; Christopher S Saigal; Mark S Litwin
Journal:  Urol Clin North Am       Date:  2009-02       Impact factor: 2.241

6.  Endoscopic treatment of vesicoureteral reflux in children with subureteral dextranomer/hyaluronic acid injection: a single-centre, 7-year experience.

Authors:  Mihovil Biočić; Jakov Todorić; Dražen Budimir; Andrea Cvitković Roić; Zenon Pogorelić; Ivo Jurić; Tomislav Šušnjar
Journal:  Can J Surg       Date:  2012-10       Impact factor: 2.089

7.  Subureteral Injection with Small-Size Dextranomer/Hyaluronic Acid Copolymer: Is It Really Efficient?

Authors:  Iyimser Üre; Serhat Gürocak; Özgür Tan; Amirali Farahvash; Cem Senol; Hüseyin Gümüstas; Irfan Atay; Nuri Deniz
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

8.  Current status of Gil-Vernet trigonoplasty technique.

Authors:  Nasser Simforoosh; Mohammad H Radfar
Journal:  Adv Urol       Date:  2008

Review 9.  Vesicoureteral reflux and bladder dysfunction.

Authors:  Hyeyoung Lee; Yong Seung Lee; Young Jae Im; Sang Won Han
Journal:  Transl Androl Urol       Date:  2012-09

10.  Medical management of vesicoureteral reflux--quiz within the article. Don't overlook placebos.

Authors:  Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2007-05-05       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.